A PHASE 2B/3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTICENTER STUDY INVESTIGATING THE EFFICACY AND SAFETY OF JNJ-54861911 IN SUBJECTS WHO ARE ASYMPTOMATIC AT RISK FOR DEVELOPING ALZHEIMER'S DEMENTIA
Principal Investigator(s)
Royall, Donald R
Funded by
JANSSEN RESEARCH & DEVELOPMENT
Research Start Date
Status
Active